Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teng Moua

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Annals of the American Thoracic Society|May 13, 2026
Prognostic Impact of Quantitative CT Disease Extent and Pattern in Fibrotic Hypersensitivity PneumonitisEvans R Fernández Pérez, Stephen M Humphries, David A Lynch, et al.
Critical Care Medicine|July 22, 2016
Mild Cognitive Impairment and Risk of Critical IllnessD Alex Teeters, Teng Moua, Guangxi Li, et al.
European Radiology|June 9, 2022
Quantitative CT and machine learning classification of fibrotic interstitial lung diseasesChi Wan Koo, James M Williams, Grace Liu, et al.
Mayo Clinic Proceedings|July 2, 2026
Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and SafetyAntonios Charokopos, Argyrios Tzouvelekis, Benjamin Stultz, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Baseline and Change in Peripheral Blood Transcriptome Enhance Outcome Prediction in Fibrotic Hypersensitivity Pneumonitis: A Prospective Multicenter Cohort StudyEvans R Fernández Pérez, Sonia M Leach, Stephen M Humphries, et al.
The Lancet. Respiratory Medicine|March 9, 2020
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U Wells, Kevin R Flaherty, Kevin K Brown, et al.
Chest|October 19, 2020
Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren'sAugustine S Lee, R Hal Scofield, Katherine Morland Hammitt, et al.
Arthritis Care & Research|November 28, 2024
Integrating patient advocacy groups in the development of clinical practice guidelines: comment on the article by Johnson et alNishant Gupta, Steven E Carsons, Nancy L Carteron, et al.
The European Respiratory Journal|September 3, 2021
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trialKevin R Flaherty, Athol U Wells, Vincent Cottin, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 21, 2020
Bronchoscopic Cryobiopsy and Forceps Biopsy for the Diagnostic Evaluation of Diffuse Parenchymal Lung Disease in Clinical PracticeMatthew Koslow, Eric S Edell, David E Midthun, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Annals of the American Thoracic Society|May 13, 2026
Prognostic Impact of Quantitative CT Disease Extent and Pattern in Fibrotic Hypersensitivity PneumonitisEvans R Fernández Pérez, Stephen M Humphries, David A Lynch, et al.
Critical Care Medicine|July 22, 2016
Mild Cognitive Impairment and Risk of Critical IllnessD Alex Teeters, Teng Moua, Guangxi Li, et al.
European Radiology|June 9, 2022
Quantitative CT and machine learning classification of fibrotic interstitial lung diseasesChi Wan Koo, James M Williams, Grace Liu, et al.
Mayo Clinic Proceedings|July 2, 2026
Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and SafetyAntonios Charokopos, Argyrios Tzouvelekis, Benjamin Stultz, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Baseline and Change in Peripheral Blood Transcriptome Enhance Outcome Prediction in Fibrotic Hypersensitivity Pneumonitis: A Prospective Multicenter Cohort StudyEvans R Fernández Pérez, Sonia M Leach, Stephen M Humphries, et al.
The Lancet. Respiratory Medicine|March 9, 2020
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U Wells, Kevin R Flaherty, Kevin K Brown, et al.
Chest|October 19, 2020
Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren'sAugustine S Lee, R Hal Scofield, Katherine Morland Hammitt, et al.
Arthritis Care & Research|November 28, 2024
Integrating patient advocacy groups in the development of clinical practice guidelines: comment on the article by Johnson et alNishant Gupta, Steven E Carsons, Nancy L Carteron, et al.
The European Respiratory Journal|September 3, 2021
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trialKevin R Flaherty, Athol U Wells, Vincent Cottin, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 21, 2020
Bronchoscopic Cryobiopsy and Forceps Biopsy for the Diagnostic Evaluation of Diffuse Parenchymal Lung Disease in Clinical PracticeMatthew Koslow, Eric S Edell, David E Midthun, et al.
Pageof 11